Ian Bezek

Ian Bezek

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Energy Transfer’s Huge Yield Isn’t Worth the Risk

Energy Transfer can maintain its unusually high dividend for the time being. But beware of holding onto ET stock too long.

Don’t Get Caught Up in the Hype of Gold Stocks

The current economic events are a plus for gold. But gold stocks have gotten ahead of themselves right now.

Why Canopy Growth Stock Is Surging Once Again

The coronavirus pandemic could be a catalyst for the marijuana stocks in more ways than one. Here's why CGC stock is rallying again.

Salesforce Stock Is a Promising Buy Ahead of Earnings

Salesforce may report a growth slowdown when it publishes earnings next week. But the long-term outlook for CRM stock remains strong.

Take Your Profits Once Tesla Stock Hits $1,000

Tesla is likely to keep racing up toward $1,000. Here's why it will happen, and the reason you should take profits then in TSLA stock.

7 Excellent Penny Stocks Ready to Roar

These seven penny stocks could have strong upside as the market continues to rebound.

Acquiring Grubhub Could Be Huge for Uber Stock in the Long Term

Uber is making the most of this difficult economic period. Buying Grubhub would expand Uber's lead over other rivals such as Lyft.

Southwest Stock Will Soar as Other Airlines Remain Grounded

Other airlines are starting to go bankrupt. As their footprints shrink, Southwest will have the opportunity to seize great routes and build its market share.

If You Think Leisure Travel Is Coming Back, JetBlue Stock Is a Great Buy

JetBlue's earnings report last week showed off the company's relative strength versus rivals. It has what it takes to ride out the economic downturn.

Dump Co-Diagnostics Stock Before It’s Too Late

After a dreadful earnings report and conference call, the good times are over for Co-Diagnostics. CODX stock will continue to sink in coming days.